[
  {
    "ts": null,
    "headline": "3 Reasons To Be Optimistic Around Biotech In Q4",
    "summary": "Biotech is outperforming the S&P 500 and NASDAQ as M&A heats up and Q4 tailwinds emerge, signaling more upside ahead. Read more on the sector breakdown here.",
    "url": "https://finnhub.io/api/news?id=2ac641d585eaf5678cb0305799e04c8c404c8ec9ed381254d4b00937ae526469",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759642937,
      "headline": "3 Reasons To Be Optimistic Around Biotech In Q4",
      "id": 136977591,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1160060870/image_1160060870.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Biotech is outperforming the S&P 500 and NASDAQ as M&A heats up and Q4 tailwinds emerge, signaling more upside ahead. Read more on the sector breakdown here.",
      "url": "https://finnhub.io/api/news?id=2ac641d585eaf5678cb0305799e04c8c404c8ec9ed381254d4b00937ae526469"
    }
  }
]